Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. - Wikidata - awgldk - TriplyDB

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

http://www.wikidata.org/entity/Q55067141

about

Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting Cardiac cachexia: hic et nunc The Role of the Multiple Hormonal Dysregulation in the Onset of "Anemia of Aging": Focus on Testosterone, IGF-1, and Thyroid Hormones Glycemic variability and glycemic control in the acutely ill cardiac patient Testosterone and the cardiovascular system: a comprehensive review of the clinical literature beta2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle Insulin Signaling and Heart Failure.Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort.Leptin resistance after heart transplantation.Insulin-like growth factor-I can be helpful towards end of life.The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.Heart failure as a metabolic problem.Malnutrition as assessed by nutritional risk index is associated with worse outcome in patients admitted with acute decompensated heart failure: an ACAP-HF data analysis.Testosterone: a natural tonic for the failing heart?A crucial role of activin A-mediated growth hormone suppression in mouse and human heart failure.Defects in insulin action in chronic heart failure.Skeletal muscle training in chronic heart failure.Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.Malnutrition in patients suffering from chronic heart failure; the nurse's care.Heart failure: What causes the symptoms of heart failure?Immune and neurohormonal pathways in chronic heart failure.Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic disease.Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia.Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart Study.Heart failure as an inflammatory condition: potential role for androgens as immune modulators.Growth hormone therapy in heart failure: where are we now?Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle Psychobiology of depression/distress in congestive heart failure Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure.Cachexia in malaria and heart failure: therapeutic considerations in clinical practice.Toward a broader understanding of aldosterone in congestive heart failure.Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure.Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.

P2860

Q24609841-EE7693D3-A100-4B81-9AB2-FE1F5D39E845 Q26744140-C8513F29-27E9-4CB0-B31E-BFE09AD9D948 Q26771431-2449136A-B9C9-47CA-908A-70F42899906E Q26821994-63AABE56-C540-4691-9B27-A6F3E8937527 Q27000507-4F2EC0D9-AD43-49DE-9D9A-E08C9DA1993D Q28582641-CAC04F76-B86D-40E7-B0C8-267B141A5095 Q30377910-1FACA81D-D4E5-4775-BD72-B52A196D05A4 Q30625276-ACC87D80-2878-4627-AEF4-83352EF165C8 Q33803821-8A0E74C6-BD05-4D9D-A66D-C8398AD20A3A Q33804564-3C67F2E6-F958-4A27-ADA7-1E0E72113D19 Q33948639-4B812F12-F732-4AAA-965A-0F2B8B5CD601 Q33999696-E68AC6AF-B657-445F-84FF-8EE8DD6F332C Q34041612-50E204E6-3BE8-467C-9522-6E54A382B684 Q34058722-3F235BBF-C0CE-471E-889E-51F026537AFA Q34116906-8187904B-9A0B-4585-AC96-E68A2A2F8F66 Q34166305-BF2D2819-1243-449F-B918-F4C95627352C Q34285829-CB752733-55FB-4422-A359-12E73329678B Q34334313-7836C36F-76AE-4DDA-B50E-338E65222876 Q34340600-DFE6E558-A8B2-42BB-94E0-9C865E255B92 Q34402297-2CB5F618-9189-4639-BA38-253819A4572E Q34513186-2667155E-C96D-4315-A430-7F68B419DF24 Q34546722-570A0E84-C04A-476E-BA80-7DDE2FFBA710 Q34570343-023EB5BF-5F36-445A-9DD9-5CF0A612B900 Q34590954-E964D4B5-3568-4164-AC32-53DC3258A749 Q34590981-871844B8-94C3-4CBA-8EB3-C8910ED24A34 Q34697156-3512E27C-2BA9-4A98-A583-03338501F9A3 Q34697244-676D4EB2-0A7F-4375-A86B-377FF8C40104 Q34768351-F9EFC003-AE39-4C7E-92AF-53AEE79AF50E Q34824162-48962621-708F-4D7B-9AC1-83020BA418E1 Q34957797-A6DDA8CF-7D6D-41B8-B4E1-A05F88163067 Q35009689-BAD7B5DC-0121-4390-80D3-AB88858F590D Q35097111-9B316A61-4738-40BC-8EAE-6D55E7ED0FBD Q35138063-ACA13628-6372-406F-A8E7-6FC5B03CF618 Q35223968-F1D51441-BE74-4049-9599-90F4815899A1 Q35293910-AEC011EC-FE86-487C-9951-12C8E499250F Q35373849-34B1700F-DB09-45E6-A7C9-BF42DBE82C4C Q35520657-D59E72E5-893E-4BCC-8DCB-163780B12E7B Q35580139-75213B15-89BA-473B-A146-328D31333571 Q35581324-4FF467B0-C572-4664-9A00-BC7B19B3E9A8 Q35583145-A3DE633C-4A8C-43D5-8321-030DA6FE141C

P2860

Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.

http://www.wikidata.org/entity/Q55067141

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh-hant

name

Hormonal changes and catabolic ...... portance for cardiac cachexia.

@en

Hormonal changes and catabolic ...... portance for cardiac cachexia.

@nl

type

label

Hormonal changes and catabolic ...... portance for cardiac cachexia.

@en

Hormonal changes and catabolic ...... portance for cardiac cachexia.

@nl

prefLabel

Hormonal changes and catabolic ...... portance for cardiac cachexia.

@en

Hormonal changes and catabolic ...... portance for cardiac cachexia.

@nl

P1433

Q55067141-1F4348B0-7582-42A9-BABF-1A2B47A57977

P1476

Q55067141-629A9EF9-87AE-44AD-84D8-42CFF3A3F40D

P2093

Q55067141-35254B96-F644-4122-B8A1-6045D38F9829

Q55067141-91E19726-F7F7-4762-8192-35F39E7ACF9D

Q55067141-AB3A0E88-9425-46F6-9AA0-721052E286CC

Q55067141-E978103D-8FB0-42DB-B711-FB8A29908611

Q55067141-F30791EF-5E7F-4B4F-BA03-A75FD4E375E3

Q55067141-F3B8719D-A9F0-43A5-8E3B-92C8E3CFB5B1

P304

Q55067141-CE0C3020-77A2-49AE-B0E3-7ED0A07C6A51

P31

Q55067141-9A41BAAC-22BD-4726-9F94-71291391C2DB

P356

Q55067141-8B09DB77-4ED6-4053-9C00-27707EC92100

P407

Q55067141-688807F4-AFFC-4F77-B2DC-402F1DA552C9

P433

Q55067141-23EED352-A407-440B-8DB1-916C27A5699E

P478

Q55067141-32EB3197-E16E-457E-A009-B2B340196841

P50

Q55067141-1413B5AC-301A-4B9F-83F4-A2F979C69871

Q55067141-8B7A8678-CC8E-47E4-A0AE-9831B1B447A7

P577

Q55067141-5BE59DF1-BE9B-4E40-951C-2E769A2FD360

P698

Q55067141-FF1ADAB9-DE05-4486-8E36-D3ABBF185F61

P921

Q55067141-A53CC02C-AC86-483C-A558-755853EA7490

P356

01.CIR.96.2.526

P1433

P1476

Hormonal changes and catabolic ...... portance for cardiac cachexia.

@en

P2093

Chua TP

http://www.w3.org/2001/XMLSchema#string

Coats AJ

http://www.w3.org/2001/XMLSchema#string

Harrington D

http://www.w3.org/2001/XMLSchema#string

Kox WJ

http://www.w3.org/2001/XMLSchema#string

Poole-Wilson PA

http://www.w3.org/2001/XMLSchema#string

Swan JW

http://www.w3.org/2001/XMLSchema#string

P304

526-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.96.2.526

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Piotr Ponikowski

Stefan D. Anker

P577

1997-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9244221

http://www.w3.org/2001/XMLSchema#string

P921